More than 2.5 millions envenomations and 125.000 death occur each year due to snakebite. Current antivenoms consist of immunoglobulinesderived from animals, and they are therefore associated with a high risk of adverse reactions in humans. The use of synthetic peptidic antitoxinsmay lead to safer and more effective antivenoms. This research reports the discovery of peptidic antitoxins against myotoxin II from B. asper.
|Number of pages||1|
|Publication status||Published - 2016|
|Event||Examenssymposium, Uppsala Universitet 2016 - Uppsala, Sweden|
Duration: 15 Jan 2016 → 15 Jan 2016
|Conference||Examenssymposium, Uppsala Universitet 2016|
|Period||15/01/2016 → 15/01/2016|